论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Yang Z, Liu J, Shi Q, Chao Y, Di Y, Sun J, Zhang J, Huang L, Guo H, He C
Received 18 October 2017
Accepted for publication 17 April 2018
Published 19 July 2018 Volume 2018:11 Pages 4159—4166
DOI https://doi.org/10.2147/OTT.S154452
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Colin Mak
Peer reviewer comments 3
Editor who approved publication: Prof. Dr. Geoffrey Pietersz
Introduction: Over 20% of colorectal
cancer (CRC) patients seek medical attention for the first time when they are
in the advanced stages of CRC. Thus, early and reliable detection of CRC is
critical to early diagnosis of CRC. Protein disulfide isomerase A3 precursor
(PDIA3) has been implicated in various types of cancers. However, little is
known about PDIA3 in CRC.
Methods: In this study, we screened PDIA3 expression in
CRC tissues and cell lines. Small interfering RNA (siRNA) was introduced into
SW480 cells to knockdown PDIA3 expression. The effect of PDIA3 in cell growth
was evaluated.
Results: Significant upregulation of PDIA3 expression was
found in CRC tissues as compared with adjacent non-cancer tissues, and was
found in established CRC cell lines (SW480, HCT116, CACO2, NCM460 and HT-29).
In SW480 cells, knockdown of PDIA3 expression with siRNA resulted in
subcellular morphological change, reduced cell proliferation and increased
apoptosis.
Conclusion: PDIA3 inhibition could suppress CRC, likely
through inducing apoptosis. PDIA3 could be a potential therapeutic target for
CRC.
Keywords: PDIA3,
colorectal cancer, proteomics, siRNA, apoptosis